Although the WBC levels did not differ significantly between the groups (p = 0.174), the significant difference in the CRP and ESR biomarker levels between the resistant and responder groups provides strong evidence of a relationship between inflammation and treatment-resistant depression. The gene discussed is CRP; the disease is depressive symptom measurement.